These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Determination of stage interconversion in vitro and in vivo by construction of transgenic Toxoplasma gondii that stably express stage-specific fluorescent proteins. Zhang H, Zhang Y, Cao J, Zhou Y, Wang N, Zhou J. Exp Parasitol; 2013 Jul; 134(3):275-80. PubMed ID: 23545429 [Abstract] [Full Text] [Related]
3. Visualization of Toxoplasma gondii stage conversion by expression of stage-specific dual fluorescent proteins. Unno A, Suzuki K, Batanova T, Cha SY, Jang HK, Kitoh K, Takashima Y. Parasitology; 2009 May; 136(6):579-88. PubMed ID: 19368740 [Abstract] [Full Text] [Related]
5. Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host. Ferguson DJ. Int J Parasitol; 2004 Mar 09; 34(3):347-60. PubMed ID: 15003495 [Abstract] [Full Text] [Related]
16. Toxoplasma gondii: Simple duplex RT-PCR assay for detecting SAG1 and BAG1 genes during stage conversion in immunosuppressed mice. Mahittikorn A, Wickert H, Sukthana Y. Exp Parasitol; 2010 Feb 09; 124(2):225-31. PubMed ID: 19854173 [Abstract] [Full Text] [Related]
17. Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii. Tan F, Hu X, Pan CW, Ding JQ, Chen XG. Parasitol Int; 2010 Jun 09; 59(2):141-6. PubMed ID: 20056166 [Abstract] [Full Text] [Related]
18. Differential expression of cell surface- and dense granule-associated Neospora caninum proteins in tachyzoites and bradyzoites. Fuchs N, Sonda S, Gottstein B, Hemphill A. J Parasitol; 1998 Aug 09; 84(4):753-8. PubMed ID: 9714206 [Abstract] [Full Text] [Related]